Lumida
/PGNY
⌘K
Progyny Inc

Progyny Inc

PGNY
$31.93USD↑+0.22%+0.07 today

MARKET CAP

2.5B

P/E (TTM)

41.5x

FWD P/E

23.9x

DAY RANGE

$31 – $32

52W RANGE

$16
$33

AI Summary

Stalk
StalkMedium

PGNY remains in a healthy Stage 2 uptrend with Parabola-driven acceleration along rising EMAs, but price is extended and in extreme overbought territory, making immediate entry unfavorable. We maintain a bullish medium-term bias while deferring execution, stalking pullbacks into the rising 9EMA/21EMA support zone for better risk/reward.

  • ↑Q1 2026 revenue $328.5M, topping guidance $315–330M
  • ↑Full-year revenue outlook lifted to $1.98–2.09B
  • ↓Weak profitability conversion, margins below industry norms
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Progyny, Inc. (NASDAQ: PGNY) is a leader in the fertility benefits sector, offering comprehensive family-building and women's health solutions through an innovative member-centric platform. Positioned within a growing healthcare market that addresses infertility challenges, Progyny is poised to capitalize on rising employer demand for comprehensive health benefits, particularly among larger self-insured clients. The company aims to enhance employee engagement and provide proven cost containment services, establishing a unique position in an increasingly competitive landscape.

Bull says

  • ↑Q1 2026 revenue $328.5M, topping guidance $315–330M
  • ↑Full-year revenue outlook lifted to $1.98–2.09B
  • ↑Q1 EPS $0.50 vs. $0.44 consensus
  • ↑Operating cash flow $46M underscores strong cash conversion
  • ↑High earnings yield, strong liquidity and low leverage risk
  • ↑CapEx rose to $18.4M to fund platform upgrades and expansion

Bear says

  • ↓Weak profitability conversion, margins below industry norms
  • ↓High CapEx ($18.4M) may compress near-term margins
  • ↓High short interest heightens share volatility
  • ↓Small market size limits scale economies
  • ↓Revenue tied to employer demand, vulnerable amid inflation
  • ↓Heavy client concentration creates revenue risk

Investment themes with PGNY

Recent IPOs↓ -0.74%

Companies that recently went public

SNOW · PLTR · PTON
Health Care Providers↓ -0.61%

UNH · CVS · HCA

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-10-2026bullish

Transcript signals

Bull points

  • We're pleased to report that we've had a good start to the year, with record first quarter revenue coming in at the higher end of our expectations, and net income, earnings per share, and adjusted EBITDA all above our guidance ranges.
  • In addition, we also made meaningful progress during the quarter in laying the foundation for future growth through our planned investments to expand the capabilities of the platform, enhance our already industry-leading member experience, and extend our position as the solution of choice in women's health and family building.
  • we're also raising our full year expectations for adjusted EBITDA, net income, and EPS as well.

Bear points

  • We recognize that investors are pricing into our valuation the potential for a negative impact on member engagement, or on employer demand for our services.
Read full transcript analysis ›